D
Evolent Health, Inc. EVH
$22.04 -$0.46-2.04%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 3/14/2023Downgrade
Evolent Health, Inc. (EVH) was downgraded to D- from D on 3/14/2023 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $0.02 to -$0.1139, and EBIT declined 155.96% from $3.84M to -$2.15M.
D
Sell 2/23/2023Upgraded
Evolent Health, Inc. (EVH) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell 2/8/2023Downgrade
Evolent Health, Inc. (EVH) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell 1/31/2023Downgrade
Evolent Health, Inc. (EVH) was downgraded to D from D+ on 1/31/2023 due to a large decline in the total return index, volatility index and solvency index.
D
Sell 11/4/2022Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from D on 11/4/2022 due to an increase in the growth index, valuation index and volatility index. EBIT increased 1,032.52% from -$412 to $3.84M, earnings per share increased from -$0.0509 to $0.02, and total revenue increased 10.2% from $319.94M to $352.59M.
D
Sell 5/31/2022Upgraded
Evolent Health, Inc. (EVH) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
D
Sell 5/13/2022Downgrade
Evolent Health, Inc. (EVH) was downgraded to D- from D on 5/13/2022 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 186.18% from $66.66M to -$57.44M, debt to equity increased from 0.32 to 0.47, and EBIT declined 11.53% from $4.22M to $3.74M.
D
Sell 5/5/2022Upgraded
Evolent Health, Inc. (EVH) was upgraded to D from D- on 5/5/2022 due to a significant increase in the total return index, valuation index and volatility index.
D
Sell 4/20/2022Downgrade
Evolent Health, Inc. (EVH) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index.
D
Sell 11/23/2021Upgraded
Evolent Health, Inc. (EVH) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index and total return index.
D
Sell 11/8/2021Downgrade
Evolent Health, Inc. (EVH) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from -$0.1066 to -$0.152.
D
Sell 8/18/2021Downgrade
Evolent Health, Inc. (EVH) was downgraded to D from D+ on 8/18/2021 due to a decline in the valuation index and solvency index. Debt to equity increased from 0.38 to 0.39.
D
Sell 2/4/2021Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from D on 2/4/2021 due to an increase in the volatility index, valuation index and total return index.
D
Sell 2/5/2019Downgrade
Evolent Health, Inc. (EVH) was downgraded to D from D+ on 2/5/2019 due to a large decline in the total return index and volatility index.
D
Sell 12/21/2018Downgrade
Evolent Health, Inc. (EVH) was downgraded to D+ from C- on 12/21/2018 due to a decline in the total return index.
C
Hold 11/28/2018Upgraded
Evolent Health, Inc. (EVH) was upgraded to C- from D+ on 11/28/2018 due to a major increase in the total return index, solvency index and volatility index. The quick ratio increased from 2 to 2.05.
D
Sell 10/30/2018Downgrade
Evolent Health, Inc. (EVH) was downgraded to D+ from C- on 10/30/2018 due to a decline in the total return index.
C
Hold 9/12/2018Upgraded
Evolent Health, Inc. (EVH) was upgraded to C- from D+ on 9/12/2018 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 127.12% from -$24.71M to $6.7M, earnings per share increased from -$0.1808 to -$0.13, and EBIT increased 22.28% from -$13.47M to -$10.47M.
D
Sell 3/12/2018Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from D on 3/12/2018 due to an increase in the total return index, efficiency index and growth index. EBIT increased 10.16% from -$13.52M to -$12.15M, total revenue increased 5.39% from $107.91M to $113.73M, and earnings per share increased from -$0.18 to -$0.1762.
D
Sell 11/28/2017Downgrade
Evolent Health, Inc. (EVH) was downgraded to D from D+ on 11/28/2017 due to a decline in the volatility index and total return index.
D
Sell 11/13/2017Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from D on 11/13/2017 due to an increase in the growth index, solvency index and efficiency index. Operating cash flow increased 207.76% from -$9.95M to $10.72M, the quick ratio increased from 1.67 to 3.14, and earnings per share increased from -$0.2842 to -$0.18.
D
Sell 11/6/2017Downgrade
Evolent Health, Inc. (EVH) was downgraded to D from D+ on 11/6/2017 due to a substantial decline in the total return index and valuation index.
D
Sell 4/20/2017Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from D on 4/20/2017 due to a large increase in the total return index and volatility index.
D
Sell 3/6/2017Downgrade
Evolent Health, Inc. (EVH) was downgraded to D from D+ on 3/6/2017 due to a substantial decline in the efficiency index, volatility index and total return index. Net income declined 55.31% from -$11.21M to -$17.41M.
D
Sell 10/31/2016Downgrade
Evolent Health, Inc. (EVH) was downgraded to D+ from C- on 10/31/2016 due to a decline in the total return index.
C
Hold 9/12/2016Upgraded
Evolent Health, Inc. (EVH) was upgraded to C- from D+ on 9/12/2016 due to a significant increase in the total return index and volatility index.
D
Sell 8/12/2016Downgrade
Evolent Health, Inc. (EVH) was downgraded to D+ from C- on 8/12/2016 due to a significant decline in the valuation index and efficiency index. Total capital declined 0.97% from $775.66M to $768.14M.
C
Hold 6/22/2016Upgraded
Evolent Health, Inc. (EVH) was upgraded to C- from D- on 6/22/2016 due to a significant increase in the valuation index and efficiency index.
D
Sell 3/1/2016Upgraded
Evolent Health, Inc. (EVH) was upgraded to D- from E+ on 03/01/2016.
E
Sell 12/3/2015Downgrade
Evolent Health, Inc. (EVH) was downgraded to E+ from D+ on 12/03/2015.
D
Sell 12/2/2015Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from E on 12/02/2015.
E
Sell 11/19/2015Downgrade
Evolent Health, Inc. (EVH) was downgraded to E from D+ on 11/19/2015.
D
Sell 11/18/2015Upgraded
Evolent Health, Inc. (EVH) was upgraded to D+ from E on 11/18/2015.
E
Sell 9/28/2015Downgrade
Evolent Health, Inc. (EVH) was downgraded to E from C- on 9/28/2015 due to a decline in the volatility index.
C
Hold 9/8/2015Upgraded
Evolent Health, Inc. (EVH) was upgraded to C- from D+ on 9/8/2015 due to a major increase in the total return index and volatility index.
D
Sell 8/28/2015None
Evolent Health, Inc. (EVH) was downgraded to D+ from U on 08/28/2015.
Weiss Ratings